Source:http://linkedlifedata.com/resource/pubmed/id/18084245
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-26
|
pubmed:abstractText |
Parenchymal destruction, airspace enlargement, and loss of elasticity are hallmarks of pulmonary emphysema. Although the basic mechanism is unknown, there is a consensus that malfunctioning of the extracellular matrix is a major contributor to the pathogenesis of emphysema. In this study, we analyzed the expression of the elastic fiber protein fibrillin-1 in a large number (n=69) of human lung specimens with early-onset emphysema. Specimens were morphologically characterized by the Destructive Index, the Mean Linear Intercept, and the Panel Grading. We observed a strong correlation (P<0.001) of aberrant fibrillin-1 staining with the degree of destruction of lung parenchyma (r=0.71), airspace enlargement (r=0.47), and emphysema-related morphological abnormalities (r=0.69). There were no obvious correlations with age and smoking behavior. Staining for three other extracellular matrix components (type I collagen, type IV collagen, and laminin) was not affected. The aberrant fibrillin-1 staining observed in this study is similar to that observed in Marfan syndrome, a syndrome caused by mutations in the gene encoding fibrillin-1. Strikingly, emphysema is noticed in a number of Marfan patients. This, together with the notion that disruption of the fibrillin-1 gene in mice results in emphysematous lesions, makes fibrillin-1 a strong candidate to be involved in the etiology and pathogenesis of emphysema.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0893-3952
|
pubmed:author |
pubmed-author:BultenJohanJ,
pubmed-author:DekhuijzenP N RichardPN,
pubmed-author:HafmansTheoT,
pubmed-author:KoendersMieke M J FMM,
pubmed-author:RobbesomAntoine AAA,
pubmed-author:SmitsNicole CNC,
pubmed-author:VeerkampJacques HJH,
pubmed-author:VersteegElly M MEM,
pubmed-author:van KuppeveltToin HTH
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
297-307
|
pubmed:meshHeading |
pubmed-meshheading:18084245-Aged,
pubmed-meshheading:18084245-Extracellular Matrix Proteins,
pubmed-meshheading:18084245-Gene Expression Regulation,
pubmed-meshheading:18084245-Genetic Predisposition to Disease,
pubmed-meshheading:18084245-Humans,
pubmed-meshheading:18084245-Immunohistochemistry,
pubmed-meshheading:18084245-Lung,
pubmed-meshheading:18084245-Microfilament Proteins,
pubmed-meshheading:18084245-Middle Aged,
pubmed-meshheading:18084245-Pulmonary Emphysema
|
pubmed:year |
2008
|
pubmed:articleTitle |
Aberrant fibrillin-1 expression in early emphysematous human lung: a proposed predisposition for emphysema.
|
pubmed:affiliation |
Department of Biochemistry, Radboud University Nijmegen Medical Center, Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|